Management of diabetic ketoacidosis in children and adolescents

Pediatric Drugs

Volumn 10, Issue 4, 2008, Pages 209-215

  Sherry, Nicole A ^a   Levitsky, Lynne L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Adolescents; Children; Diabetic ketoacidosis, treatment; Insulin aspart, therapeutic use; Insulin glulisine, therapeutic use; Insulin lispro, therapeutic use; Insulin, therapeutic use

Indexed keywords

BICARBONATE; BUMETANIDE; ELECTROLYTE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; MANNITOL; PANCREAS ENZYME; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

ARTERY OCCLUSION; AUTOREGULATION; BASILAR ARTERY; BRAIN DISEASE; BRAIN EDEMA; BRAIN INFARCTION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG ABSORPTION; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; ELECTROLYTE INTAKE; FLUID THERAPY; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; MENINGOENCEPHALITIS; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; OSMOLALITY; PANCREATITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; THIAMINE DEFICIENCY;

ADOLESCENT; BICARBONATES; BRAIN EDEMA; CHILD; DIABETIC KETOACIDOSIS; ELECTROLYTES; FLUID THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 46349088832     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200810040-00002     Document Type: Review

References (49)

1. Barnes AJ, Bloom SR, Goerge K, et al. Ketoacidosis in pancreatectomized man. N Engl J Med 1977; 296 (22): 1250-3
2. Lanng S, Hansen A, Thorsteinsson B, et al. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995; 311: 655-9
3. Nabarro JDN, Spencer AG, Stowers JM. Metabolic studies in severe diabetic ketosis. Q J Med 1952; 82: 225-48
4. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23 (3): 381-9
5. Laffel LM, Wentzell K, Loughlin C, et al. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med 2006; 23 (3): 278-84
6. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13 (1): 22-33
7. Muir AB, Quisling RG, Yang MC, et al. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care 2004; 27 (7): 1541-6
8. Glaser N, Barnett P, McCaslin I, et al., on behalf of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk factors for cerebral edema in children with diabetic ketoacidosis: The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med 2001; 344 (4): 264-9
9. Glaser NS, Wootton-Gorges SL, Marcin JP, et al. Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 2004; 145 (2): 164-71
10. Roberts JS, Vavilala MS, Schenkman KA, et al. Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children. Crit Care Med 2006; 34 (8): 2217-23
11. Figueroa RE, Hoffman WH, Momin Z, et al. Study of subclinical cerebral edema in diabetic ketoacidosis by magnetic resonance imaging T2 relaxometry and apparent diffusion coefficient maps. Endocr Res 2005; 31 (4): 345-55
12. Clark JA, Burny I, Sarnaik AP, et al. Acute thiamine deficiency in diabetic ketoacidosis: diagnosis and management. Pediatr Crit Care Med 2006; 7 (6): 595-9
13. Haddad NG, Croffie JM, Eugster EA. Pancreatic enzyme elevations in children with diabetic ketoacidosis. J Pediatr 2004; 145 (1): 122-4
14. Carl GF, Hoffman WH, Passmore GG, et al. Diabetic ketoacidosis promotes a prothrombotic state. Endocr Res 2003; 29 (1): 73-82
15. Worly JM, Fortenberry JD, Hansen I, et al. Deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous catheters. Pediatrics 2004; 113 (1): e57-60
16. Gutierrez JA, Bagatell R, Samson MP, et al. Femoral central venous catheter-associated deep venous thrombosis in children with diabetic ketoacidosis. Crit Care Med 2003; 31 (1): 80-3
17. Casteels K, Beckers D, Wouters C. Rhabdomyolysis in diabetic ketoacidosis. Pediatr Diabetes 2003; 4 (1): 29-31
18. Koves IH, Neutze J, Donath S, et al. The accuracy of clinical assessment of dehydration during diabetic ketoacidosis in childhood. Diabetes Care 2004; 27 (10): 2485-7
19. Hanas R, Donaghue K, Klingensmith G, et al., editors of the ISPAD. Clinical practice consensus guidelines 2006-2007. Pediatr Diabetes 2006; 7 (6): 341-2
20. Wolfsdorf J, Glaser N, Sperling MA, et al. Diabetic ketoacidosis in infants, children and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29 (5): 1150-9
21. Kitabchi AE, Umpierrez GE, Murphy MB, et al., on behalf of the American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care 2004; 27 (Suppl. 1) S94-102
22. Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia 2006; 49 (9): 2002-9
23. Hoorn EJ, Carlotti AP, Costa LA, et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr 2007; 150 (5): 467-73
24. Wilson HK, Keuer SP, Lea AS, et al. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med 1982; 142 (3): 517-20
25. Rachmiel M, Perlman K, Daneman D. Insulin analogues in children and teens with type 1 diabetes: advantages and caveats. Pediatr Clin North Am 2005; 52 (6): 1651-75
26. Hirsch IB. Insulin analogues. N Engl J Med. 2005; 352 (2): 174-83
27. Danne T, Becker RH, Heise T, et al. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 2005; 28 (9): 2100-5
28. Homko C, Deluzio A, Jimenez C, et al. Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects. Diabetes Care 2003; 26 (7): 2027-31
29. Stephens JM, Sulway MJ, Watkins PJ. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 1971; 20 (7): 485-9
30. Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2007 Jun; 8 (3): 150-6
31. Prisco F, Picardi A, Iafusco D, et al. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study). Pediatr Diabetes 2006; 7 (4): 223-8
32. Green SM, Rothrock SG, Ho JD, et al. Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med 1998; 31 (1): 41-8
33. Taylor CJ, Nicola PA, Wang S, et al. Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J Physiol 2006; 576 (Pt 3): 769-85
34. Dunger DB, Edge JA. Predicting cerebral edema during diabetic ketoacidosis. N Engl J Med 2001 Jan; 344 (4): 302-3
35. Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 2004; 89 (2): 188-94
36. Dunger DB, Sperling MA, Acerini CL, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 2004; 113 (2): e133-40
37. Bastin ME, Carpenter TK, Armitage PA, et al. Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. Am J Neuroradiol 2006; 27: 402-8
38. Shabbir N, Oberfield SE, Corrales R, et al. Recovery from symptomatic brain swelling in diabetic ketoacidosis. Clin Pediatr (Phila) 1992; 31 (9): 570-3
39. Tasker RC, Lutman D, Peters MJ. Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med 2005; 6 (4): 405-11
40. Marcin JP, Glaser N, Barnett P, et al., on behalf of The Pediatric Emergency Medicine Collaborative Research Committee. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr 2002; 141 (6): 793-7
41. Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in new case of insulin-dependent diabetes mellitus. Pediatrics 1982; 69 (1): 87-90
42. Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes 2001; 2 (3): 109-14
43. Yildizdas D, Altunbasak S, Celik U, et al. Hypertonic saline treatment in children with cerebral edema. Indian Pediatr 2006; 43 (9): 771-9
44. Kamat P, Vats A, Gross M, et al. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatr Crit Care Med 2003; 4 (2): 239-42
45. Della Manna T, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care 2005; 28 (8): 1856-61
46. Umpierrez GE, Cuervo R, Karabell A, et al. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 2004; 27 (8): 1873-8
47. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004; 117 (5): 291-6
48. Ersoz HO, Ukinc K, Kose M, et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract 2006; 60 (4): 429-33
49. Lam TI, Anderson SE, Glaser N, et al. Bumetanide reduces cerebral edema formation in rats with diabetic ketoacidosis. Diabetes 2005; 54 (2): 510-6